United States v. Brummett

CourtCourt of Appeals for the Tenth Circuit
DecidedAugust 1, 2000
Docket99-6279
StatusUnpublished

This text of United States v. Brummett (United States v. Brummett) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Brummett, (10th Cir. 2000).

Opinion

F I L E D United States Court of Appeals Tenth Circuit UNITED STATES COURT OF APPEALS AUG 1 2000 FOR THE TENTH CIRCUIT PATRICK FISHER Clerk

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

v. No. 99-6279 (D.C. No. 98-CR-185-M) GLEN E. BRUMMETT, (W.D. Okla.)

Defendant-Appellant.

ORDER AND JUDGMENT *

Before BRORBY , ANDERSON , and MURPHY , Circuit Judges.

After examining the briefs and appellate record, this panel has determined

unanimously that oral argument would not materially assist the determination of

this appeal. See Fed. R. App. P. 34(a)(2); 10th Cir. R. 34.1(G). The case is

therefore ordered submitted without oral argument.

Defendant Glen E. Brummett pleaded guilty to possession of

pseudoephedrine with intent to manufacture methamphetamine. On appeal, he

* This order and judgment is not binding precedent, except under the doctrines of law of the case, res judicata, and collateral estoppel. The court generally disfavors the citation of orders and judgments; nevertheless, an order and judgment may be cited under the terms and conditions of 10th Cir. R. 36.3. challenges only the sentence imposed by the district court, contending that the

court should not have based his sentence on the amount of “actual”

methamphetamine he could have produced. We have jurisdiction under 18 U.S.C.

§ 3742(a) and 28 U.S.C. § 1291 and affirm.

Charges against Brummett resulted from an investigation into an alleged

conspiracy to manufacture and distribute drugs within the Federal Correctional

Institution at El Reno, Oklahoma. The investigation targeted Brummett, a

counselor employed at the facility, and Roy Wells, an inmate, and led to a

seven-count indictment against Brummett and Wells. Brummett pleaded guilty to

count five, possession of a List I controlled substance (pseudoephedrine) with

intent to manufacture methamphetamine and aiding and abetting, in violation of

21 U.S.C. § 841(d)(1) and 18 U.S.C. § 2. The district court determined that based

on the amount of pseudoephedrine Brummett possessed and the manufacturing

method he used, he could have produced 100.25 grams of methamphetamine

(actual), resulting in a base offense level of thirty-two. 1 The court granted him a

two-level reduction pursuant to USSG §§ 2D1.1(b)(6) and 5C1.2 for the exception

to the mandatory minimum sentence. With the resulting offense level of thirty,

together with Brummett’s criminal history category of I, the applicable sentencing

1 The court also considered a small amount of marijuana seized from Brummett, but the quantity of marijuana does not affect the sentence.

-2- range was 97 to 121 months, and the court sentenced Brummett, inter alia, to

97 months’ imprisonment. 2

On appeal, Brummett challenges on two grounds the district court’s

determination of the purity of methamphetamine on which the court based its

sentence. First, he contends that the government breached the plea agreement by

arguing for a sentence based on “actual” or “pure” methamphetamine rather than

on a mixture containing methamphetamine. Second, he contends that the district

court erred in finding that the methamphetamine he could have produced would

have been actual methamphetamine rather than a mixture. “We review the district

court’s legal interpretation and application of the sentencing guidelines de novo

and review the court’s factual findings for clear error, giving due deference to the

district court’s application of the guidelines to the facts.” United States v. Henry ,

164 F.3d 1304, 1310 (10th Cir.), cert. denied , 527 U.S. 1029 (1999). The court’s

determination of the drug quantity for which a defendant is responsible is a

factual matter we review for clear error. See United States v. Wacker , 72 F.3d

1453, 1477 (10th Cir. 1995).

2 Wells also pleaded guilty to one count of the indictment, possession of pseudoephedrine with intent to manufacture methamphetamine, in violation of 21 U.S.C. § 841(d)(1), and was sentenced, inter alia, to the statutory maximum of twenty years’ imprisonment. In a separate order and judgment, we have affirmed Wells’ sentence. See United States v. Wells , No. 99-6315 (10th Cir. August ___, 2000).

-3- The sentencing guidelines 3 provide two ways of calculating the base

offense level for methamphetamine convictions: one based on the quantity of a

mixture containing methamphetamine, and the other based on the amount of pure

or actual methamphetamine contained in the mixture. See USSG § 2D1.1(c)

n.(B); United States v. Gigley , 213 F.3d 509, 518 (10th Cir. 2000). For

comparable quantities, pure methamphetamine generates a higher offense level

than a mixture containing methamphetamine. Here, the district court’s

determination that Brummett could produce 100.25 grams of pure

methamphetamine resulted in a base offense level of thirty-two, while Brummett

contends that had the court used the appropriate mixture quantity of 277 grams,

the offense level would have been twenty-eight. The sentencing guidelines direct

the district court to use either the offense level determined based on the entire

weight of the mixture or that based on the weight of the actual methamphetamine

contained in the mixture, whichever is greater. See USSG § 2D1.1(c) n.(B);

Gigley , 213 F.3d at 519.

Brummett’s plea agreement contained two stipulations he contends are

relevant to his argument on appeal:

(5) All parties believe, based on the available facts, that defendant Glen E. Brummett’s methamphetamine manufacturing

3 The 1998 version of the United States Sentencing Guidelines applies to this case.

-4- process had a 60 percent reduction rate in converting pseudoephedrine to methamphetamine;

(6) All parties believe, based on the available facts (including an [Oklahoma State Bureau of Investigation] chemist’s report), that defendant Glen E. Brummett possessed 514.3 grams of pseudoephedrine for the purpose of manufacturing methamphetamine . . . .

Appellant’s Suppl. App. at 8.

Brummett contends that the government breached the plea agreement

because it stipulated in the agreement to the amount of methamphetamine he

could produce, but then argued that he should be sentenced based on actual

methamphetamine . He acknowledges that he failed to raise this issue in the

district court and thus requests that we review it for plain error. See Appellant’s

Reply Br. at 2. However, as this citation indicates, he failed to raise this issue

until his reply brief, and we do not consider, even under a plain error standard,

issues raised for the first time in a reply. See United States v. Murray , 82 F.3d

361, 363 n.3 (10th Cir. 1996); United States v. Hardwell , 80 F.3d 1471, 1495

(10th Cir. 1996).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Murray
82 F.3d 361 (Tenth Circuit, 1996)
United States v. Henry
164 F.3d 1304 (Tenth Circuit, 1999)
United States v. Joseph Vincent Hunt
171 F.3d 1192 (Eighth Circuit, 1999)
United States v. Wacker
72 F.3d 1453 (Tenth Circuit, 1995)
United States v. Hardwell
80 F.3d 1471 (Tenth Circuit, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Brummett, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-brummett-ca10-2000.